Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

Paolo Maria Rossini, M Bousser, P Amarenco, A Chamorro, M Fisher, I Ford, Km Fox, Mg Hennerici, Hp Mattle, Pm Rothwell, A De Cordoüe, M Fratacci

Risultato della ricerca: Contributo in rivistaArticolo in rivista

168 Citazioni (Scopus)

Abstract

Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischaemic events in patients with a recent non-cardioembolic cerebral ischaemic event.
Lingua originaleEnglish
pagine (da-a)2013-2022
Numero di pagine10
RivistaLANCET
Volume377
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Aged
  • Aspirin
  • Double-Blind Method
  • Female
  • Humans
  • Ischemic Attack, Transient
  • Male
  • Middle Aged
  • Naphthalenes
  • Platelet Aggregation Inhibitors
  • Propionic Acids
  • Receptors, Thromboxane
  • Secondary Prevention
  • Stroke
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial'. Insieme formano una fingerprint unica.

Cita questo